Acromegaly: Role of surgery in the therapeutic armamentarium

International Journal of Endocrinology

Volumn 2012, Issue , 2012, Pages

  Guinto, Gerardo ^a,b   Abdo, Miguel ^a   Zepeda, Erick ^a   Aréchiga, Norma ^a,b   Mercado, Moisés ^a  

^a HOSPITAL DE ESPECIALIDADES   (Mexico)

^b Nutrition and Obesity Center   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

BROMOCRIPTINE; CABERGOLINE; GROWTH HORMONE; PEGVISOMANT; QUINAGOLIDE; SOMATOMEDIN C; SOMATOSTATIN DERIVATIVE;

ACROMEGALY; CAVERNOUS SINUS; CLINICAL DECISION MAKING; CLINICAL EFFECTIVENESS; CLINICAL FEATURE; DISEASE ASSOCIATION; DISEASE CONTROL; ENDOCRINE SURGERY; EXTERNAL BEAM RADIOTHERAPY; HORMONE DETERMINATION; HUMAN; INCIDENCE; ORAL GLUCOSE TOLERANCE TEST; OUTCOME ASSESSMENT; POSTOPERATIVE COMPLICATION; PREDICTION; PREOPERATIVE CARE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RECURRENT DISEASE; REVIEW; SURGICAL APPROACH; TREATMENT CONTRAINDICATION; TREATMENT INDICATION; TUMOR LOCALIZATION; TUMOR REGRESSION;

EID: 84871376575     PISSN: 16878337     EISSN: 16878345     Source Type: Journal    
DOI: 10.1155/2012/306094     Document Type: Review

References (42)

1. Melmed S., Acromegaly pathogenesis and treatment. The Journal of Clinical Investigation 2009 119 11 3189 3202 2-s2.0-70449366466 10.1172/JCI39375
2. Vance M., Krisht A. F., Tindall T. G., Pituitary disorders: comprehensive management. Growth Hormone-Secreting Adenomas 1999 Lippincott Williams & Wilkins 235 242
3. Lonser R. R., Kindzelski B. A., Mehta G. U., Jane J. A., Oldfield E. H., Acromegaly without imaging evidence of pituitary adenoma. Journal of Clinical Endocrinology and Metabolism 2010 95 9 4192 4196 2-s2.0-77956566544 10.1210/jc.2010-0570
4. Thapar K., Laws E., Krisht A. F., Tindall T., Pituitary disorders: comprehensive management. Growth Hormone-Secreting Pituitary Tumors: Operative Management 1999 Lippincott Williams & Wilkins 243 258
5. Melmed S., Colao A., Barkan A., Molitch M., Grossman A. B., Kleinberg D., Clemmons D., Chanson P., Laws E., Schlechte J., Vance M. L., Ho K., Giustina A., Guidelines for acromegaly management: an update. Journal of Clinical Endocrinology and Metabolism 2009 94 5 1509 1517 2-s2.0-66149130384 10.1210/jc.2008-2421
6. Guinto-Balanzar G., López-Félix B. E., Cohn-Zurita F., Pérez-Pérez V. H., Nettel-Rueda B., Domínguez-Cortinas F., Macroadenomas de hipófisis. Un reto neuroquirúrgico. Cirugia y Cirujanos 2003 71 5 350 358 2-s2.0-18144449290
7. Amar A. P., Weiss M. H., Pituitary anatomy and physiology. Neurosurgery Clinics of North America 2003 14 1 11 23 2-s2.0-0037262477 10.1016/S1042- 3680(02)00017-7 (Pubitemid 36184304)
8. Sloan A., Black K., Becker D., Lesions of the Sella Turcica: Surgery of the Skull Base 1998 Philadelphia, Pa, USA Lippincot-Raven Publishers
9. Guinto G., Abdo M., Contreras R., Manejo Quirúrgico de los Macroadenomas de Hipófisis no Funcionantes. Focus Neuroendocrinoló gico 2011 3 4 10
10. Arellano S., Aguilar P., Domínguez B., Segundo Consenso Nacional de Acromegalia: recomendaciones para su diagnóstico, tratamiento y seguimiento. Revista de Endocrinología y Nutrición 2007 15 7 16
11. Sata A., Ho K. K. Y., Growth hormone measurements in the diagnosis and monitoring of acromegaly. Pituitary 2007 10 2 165 172 2-s2.0-34249902790 10.1007/s11102-007-0034-x (Pubitemid 46863731)
12. Bidlingmaier M., Strasburger C. J., Growth hormone assays: current methodologies and their limitations. Pituitary 2007 10 2 115 119 2-s2.0-34249900190 10.1007/s11102-007-0030-1 (Pubitemid 46863725)
13. Brooke A. M., Drake W. M., Serum IGF-I levels in the diagnosis and monitoring of acromegaly. Pituitary 2007 10 2 173 179 2-s2.0-34249881623 10.1007/s11102-007-0036-8 (Pubitemid 46863732)
14. Giustina A., Chanson P., Bronstein M. D., Klibanski A., Lamberts S., Casanueva F. F., Trainer P., Ghigo E., Ho K., Melmed S., A consensus on criteria for cure of acromegaly. Journal of Clinical Endocrinology and Metabolism 2010 95 7 3141 3148 2-s2.0-77954926018 10.1210/jc.2009-2670
15. Manjila S., Wu O. C., Khan F. R., Khan M. M., Arafah B. M., Selman W. R., Pharmacological management of acromegaly: a current perspective. Neurosurgical Focus 2010 29 4 1 9 2-s2.0-78049416796 10.3171/2010.7.FOCUS10168
16. Ciric I., Mikhael M., Stafford T., Transsphenoidal microsurgery of pituitary macroadenomas with long-term follow-up results. Journal of Neurosurgery 1983 59 3 395 401 2-s2.0-0020505872 (Pubitemid 13048132)
17. Jane J. A., Thapar K., Kaptain G. J., Maartens N., Laws E. R., Mayberg M. R., Ciric I. S., Chandler W. F., Post K. D., Pituitary surgery: transsphenoidal approach. Neurosurgery 2002 51 2 435 444 2-s2.0-0036705583 10.1097/00006123- 200208000-00025 (Pubitemid 36322737)
18. Barkan A., Bronstein M. D., Bruno O. D., Cob A., Espinosa-de-los-Monteros A. L., Gadelha M. R., Garavito G., Guitelman M., Mangupli R., Mercado M., Portocarrero L., Sheppard M., Management of acromegaly in Latin America: expert panel recommendations. Pituitary 2010 13 2 168 175 2-s2.0-77955907906 10.1007/s11102-009-0206-y
19. Davis P. C., Gokhale K. A., Joseph G. J., Peterman S. B., Adams D. A., Tindall G. T., Hudgins P. A., Hoffman J. C. Jr., Pituitary adenoma: correlation of half-dose gadolinium-enhanced MR imaging with surgical findings in 26 patients. Radiology 1991 180 779 784
20. Laws E. R. Jr., Cooper P. R., Neurosurgical management of acromegaly. Contemporary Diagnosis and Management of Pituitary Adenomas 1990 Park Ridge, Ill, USA American Association of Neurological Surgeons 53 59
21. Colao A., Auriemma R. S., Galdiero M., Lombardi G., Pivonello R., Effects of initial therapy for five years with somatostatin analogs for acromegaly on growth hormone and insulin-like growth factor-I levels, tumor shrinkage, and cardiovascular disease: a prospective study. Journal of Clinical Endocrinology and Metabolism 2009 94 10 3746 3756 2-s2.0-70349900717 10.1210/jc.2009-0941
22. Mercado M., Espinosa de los Monteros A. L., Sosa E., Cheng S., Mendoza V., Hernández I., Sandoval C., Guinto G., Molina M., Clinical-biochemical correlations in acromegaly at diagnosis and the real prevalence of biochemically discordant disease. Hormone Research 2004 62 6 293 299 2-s2.0-11244329010 10.1159/000082032 (Pubitemid 40069628)
23. Espinosa-de-los-Monteros A. L., Sosa E., Cheng S., Ochoa R., Sandoval C., Guinto G., Mendoza V., Hernández I., Molina M., Mercado M., Biochemical evaluation of disease activity after pituitary surgery in acromegaly: a critical analysis of patients who spontaneously change disease status. Clinical Endocrinology 2006 64 3 245 249 2-s2.0-33644957309 10.1111/j.1365-2265.2006. 02430.x
24. Vance M. L., Laws E. R., Role of medical therapy in the management of acromegaly. Neurosurgery 2005 56 5 877 885 2-s2.0-18244370517 10.1227/01.NEU.0000158322.96993.6D (Pubitemid 40628072)
25. Guinto G., Abdo M., Mercado M., Guinto P., Nishimura E., Arechiga N., Diaphragma sellae: a surgical reference for transsphenoidal resection of pituitary macroadenomas. World Neurosurgery 2011 75 2 286 293 2-s2.0-79953863421 10.1016/j.wneu.2010.08.002
26. Oyen W. J. G., Pieters G. F. F. M., Meijer E., Van Laarhoven J., Smals A. G. H., Kloppenborg P. W. C., Which factors predict the results of pituitary surgery in acromegaly? Acta Endocrinologica 1988 117 4 491 496 2-s2.0-0023939258 (Pubitemid 18096246)
27. Tindall G. T., Oyesiku N. M., Watts N. B., Clark R. V., Christy J. H., Adams D. A., Transsphenoidal adenomectomy for growth hormone-secreting pituitary adenomas in acromegaly: outcome analysis and determinants of failure. Journal of Neurosurgery 1993 78 2 205 215 2-s2.0-0027448417 (Pubitemid 23039120)
28. Ross D. A., Wilson C. B., Results of transsphenoidal microsurgery for growth hormone-secreting pituitary adenoma in a series of 214 patients. Journal of Neurosurgery 1988 68 6 854 867 2-s2.0-0023930012
29. Vance M. Lee, Medical treatment of functional pituitary tumors. Neurosurgery Clinics of North America 2003 14 1 81 87 2-s2.0-0037269494 10.1016/S1042-3680(02)00072-4 (Pubitemid 36184308)
30. Freda P. U., Reyes C. M., Nuruzzaman A. T., Sundeen R. E., Bruce J. N., Basal and glucose-suppressed GH levels less than 1 g/L in newly diagnosed acromegaly. Pituitary 2003 6 4 175 180 2-s2.0-3142667461 10.1023/B:PITU. 0000023424.72021.e2 (Pubitemid 39127616)
31. Plöckinger U., Medical therapy of acromegaly. International Journal of Endocrinology 2012 2012 22 268957 10.1155/2012/268957
32. Guyton A., Hall J., Pituitary Hormones and Their Control by the Hypothalamus: Textbook of Medical Physiology 2006 11th chapter 75 Philadelphia, Pa, USA Elsevier Saunders
33. Freda P. U., Somatostatin analogs in acromegaly. Journal of Clinical Endocrinology and Metabolism 2002 87 7 3013 3018 2-s2.0-0036319414 10.1210/jc.87.7.3013 (Pubitemid 34816336)
34. Stewart P. M., Kane K. F., Stewart S. E., Lancranjan I., Sheppard M. C., Depot long-acting somatostatin analog (sandostatin-LAR) is an effective treatment for acromegaly. Journal of Clinical Endocrinology and Metabolism 1995 80 11 3267 3272 2-s2.0-0028864383 10.1210/jc.80.11.3267
35. Colao A., Ferone D., Marzullo P., Di Sarno A., Cerbone G., Sarnacchiaro F., Cirillo S., Merola B., Lombardi G., Effect of different dopaminergic agents in the treatment of acromegaly. Journal of Clinical Endocrinology and Metabolism 1997 82 2 518 523 2-s2.0-0031026529 10.1210/jc.82.2.518 (Pubitemid 27068622)
36. Merza Z., Modern treatment of acromegaly. Postgraduate Medical Journal 2003 79 930 189 194 2-s2.0-0037851763 10.1136/pmj.79.930.189 (Pubitemid 36605779)
37. Minniti G., Scaringi C., Maurizi R., Radiation techniques for acromegaly. Radiation Oncology 2011 6 167 1 8
38. Consensus statement. Radiosurgery Practice Guideline Initiative. Stereotactic Radiosurgery for Patients with Pituitary Adenomas, April 2004
39. Jenkins P. J., Bates P., Carson M. N., Stewart P. M., Wass J. A. H., Conventional pituitary irradiation is effective in lowering serum growth hormone and insulin-like growth factor-I in patients with acromegaly. Journal of Clinical Endocrinology and Metabolism 2006 91 4 1239 1245 2-s2.0-33646060089 10.1210/jc.2005-1616
40. Jane J. Jr., Starke R. M., Elzoghby M. A., Endoscopic transsphenoidal surgery for acromegaly: remission using modern criteria, complications, and predictors of outcome. The Journal of Clinical Endocrinology & Metabolism 2011 96 2732 2740
41. Grasso L. F., Pivonello R., Colao A., Somatostatin analogs as a first-line treatment in acromegaly: when is it appropriate? Current Opinion in Endocrinology, Diabetes, and Obesity 2012 19 288 294
42. Katznelson L., Atkinson J. L. D., Cook D. M., Ezzat S. Z., Hamrahian A. H., Miller K. K., Medical guidelines for clinical practice for the diagnosis and treatment of acromegaly. Endocrine Practice 2011 17 supplement 4 1 44